Recent Insider Transactions - Karyopharm Therapeutics (NASDAQ: KPTI)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ KPTI Karyopharm Therapeutics

Paulson Richard A. / director, officer: President and CEO

04/04/2025

Sell

$3.74

245

$916

82,739

NASDAQ KPTI Karyopharm Therapeutics

Mano Michael / officer: SVP, General Counsel&Secretary

03/04/2025

Sell

$6.29

2,793

$18K

21,047

NASDAQ KPTI Karyopharm Therapeutics

Cheng Sohanya Roshan / officer: EVP & Chief Commercial Officer

02/28/2025

Buy

$7.95

10,833

$86K

10,833

NASDAQ KPTI Karyopharm Therapeutics

Cheng Sohanya Roshan / officer: EVP & Chief Commercial Officer

02/28/2025

Buy

$7.95

9,166

$73K

9,166

NASDAQ KPTI Karyopharm Therapeutics

Rangwala Reshma / officer: EVP & Chief Medical Officer

02/28/2025

Buy

$7.95

10,833

$86K

10,833

NASDAQ KPTI Karyopharm Therapeutics

Rangwala Reshma / officer: EVP & Chief Medical Officer

02/28/2025

Buy

$7.95

9,166

$73K

9,166

NASDAQ KPTI Karyopharm Therapeutics

Poulton Stuart / officer: EVP, Chief Development Officer

02/28/2025

Buy

$7.95

10,000

$80K

10,000

NASDAQ KPTI Karyopharm Therapeutics

Poulton Stuart / officer: EVP, Chief Development Officer

02/28/2025

Buy

$7.95

9,166

$73K

9,166

NASDAQ KPTI Karyopharm Therapeutics

Abate Kristin / officer: Chief Accounting Officer

02/28/2025

Buy

$7.95

1,866

$15K

1,866

NASDAQ KPTI Karyopharm Therapeutics

Paulson Richard A. / director, officer: President and CEO

02/28/2025

Buy

$7.95

40,000

$318K

40,000

NASDAQ KPTI Karyopharm Therapeutics

Mano Michael / officer: SVP, General Counsel&Secretary

02/28/2025

Buy

$7.95

6,666

$53K

6,666

NASDAQ KPTI Karyopharm Therapeutics

Mano Michael / officer: SVP, General Counsel&Secretary

02/28/2025

Buy

$7.95

4,500

$36K

4,500